Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription

By Ghaffari Seyed H.   Momeny Majid   Bashash Davood   Mirzaei Roohollah   Ghavamzadeh Ardeshir   Alimoghaddam Kamran  

Hematology, Vol. 17, Iss. 4, 2012-07 ,pp. : 198-206

Maney Publishing

Access to resources Recommend Favorite

Mechanisms of action and resistance to all- trans retinoic acid (ATRA) and arsenic trioxide (As 2 O 3 ) in acute promyelocytic leukemia

By Tomita Akihiro  

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 717-725

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of acute promyelocytic Leukemia and other hematologic malignancies with arsenic trioxide: Review of clinical and basic studies

By Liu Peng   Han Zhong  

International Journal of Hematology, Vol. 78, Iss. 1, 2003-02 ,pp. : 32-39

Springer Publishing Company

Access to resources Recommend Favorite

Oral arsenic trioxide therapy for acute promyelocytic leukemia before and after liver transplantation for hepatitis B virus-related liver failure

By Au Wing-Yan   Liu Chi-Leung   Tam Sidney   Fong Bonnie   Shek Tony   Hui Chee-Kin   Kwong Yok-Lam  

Annals of Hematology, Vol. 86, Iss. 10, 2007-10 ,pp. : 771-772

Springer Publishing Company

Access to resources Recommend Favorite

Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia

By Narita M.   Takahashi M.   Liu A.   Nikkuni K.   Furukawa T.   Toba K.   Koyama S.   Takai K.   Sanada M.   Aizawa Y.  

Experimental Hematology, Vol. 29, Iss. 6, 2001-06 ,pp. : 709-719

Elsevier

Access to resources Recommend Favorite